BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12497212)

  • 21. Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Int J Oncol; 2005 Jun; 26(6):1563-7. PubMed ID: 15870870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer.
    Tran HM; Shi G; Li G; Carney JP; O'Malley B; Li D
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):477-84. PubMed ID: 15467621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.
    Zuco V; Zanchi C; Cassinelli G; Lanzi C; Supino R; Pisano C; Zanier R; Giordano V; Garattini E; Zunino F
    Cell Death Differ; 2004 Mar; 11(3):280-9. PubMed ID: 14657960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy.
    Preto A; Singhrao SK; Haughton MF; Kipling D; Wynford-Thomas D; Jones CJ
    Oncogene; 2004 May; 23(23):4136-45. PubMed ID: 15064743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
    Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
    Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression.
    Bossi G; Lapi E; Strano S; Rinaldo C; Blandino G; Sacchi A
    Oncogene; 2006 Jan; 25(2):304-9. PubMed ID: 16170357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.
    Woods DC; Alvarez C; Johnson AL
    Gynecol Oncol; 2008 Mar; 108(3):632-40. PubMed ID: 18191995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of serum starvation on radiosensitivity, proliferation and apoptosis in four human tumor cell lines with different p53 status.
    Oya N; Zölzer F; Werner F; Streffer C
    Strahlenther Onkol; 2003 Feb; 179(2):99-106. PubMed ID: 12590320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14-3-3sigma-dependent resistance to cisplatin.
    Han Z; Dimas K; Tian X; Wang Y; Hemmi H; Yamada K; Kato N; Pantazis P; Ramanujam RJ; Anant S; Wyche JH; Houchen CW
    Anticancer Res; 2009 Jun; 29(6):2009-14. PubMed ID: 19528459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
    Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
    Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis.
    Skjøth IH; Issinger OG
    Int J Oncol; 2006 Jan; 28(1):217-29. PubMed ID: 16327999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
    Sheard MA; Uldrijan S; Vojtesek B
    Cancer Res; 2003 Nov; 63(21):7176-84. PubMed ID: 14612511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycerol enhances CDDP-induced growth inhibition of thyroid anaplastic carcinoma tumor carrying mutated p53 gene.
    Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Kanata H; Yane K; Hosoi H; Ohnishi T
    Oncol Rep; 2004 Apr; 11(4):821-4. PubMed ID: 15010879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R; Krausz E; Helenius H; Hietanen S
    Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells.
    Böhnke A; Westphal F; Schmidt A; El-Awady RA; Dahm-Daphi J
    Int J Radiat Biol; 2004 Jan; 80(1):53-63. PubMed ID: 14761850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.
    Beuvink I; Boulay A; Fumagalli S; Zilbermann F; Ruetz S; O'Reilly T; Natt F; Hall J; Lane HA; Thomas G
    Cell; 2005 Mar; 120(6):747-59. PubMed ID: 15797377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modes of action of artesunate in tumor cell lines.
    Efferth T; Sauerbrey A; Olbrich A; Gebhart E; Rauch P; Weber HO; Hengstler JG; Halatsch ME; Volm M; Tew KD; Ross DD; Funk JO
    Mol Pharmacol; 2003 Aug; 64(2):382-94. PubMed ID: 12869643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.